000 01742 a2200433 4500
005 20250515032228.0
264 0 _c20060928
008 200609s 0 0 eng d
022 _a1524-9557
024 7 _a10.1097/01.cji.0000203081.43235.d7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLefebvre, Marie-Laure
245 0 0 _aEx vivo-activated human macrophages kill chronic lymphocytic leukemia cells in the presence of rituximab: mechanism of antibody-dependent cellular cytotoxicity and impact of human serum.
_h[electronic resource]
260 _bJournal of immunotherapy (Hagerstown, Md. : 1997)
_c
300 _a388-97 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntibodies, Monoclonal
_xpharmacology
650 0 4 _aAntibodies, Monoclonal, Murine-Derived
650 0 4 _aAntibody-Dependent Cell Cytotoxicity
_ximmunology
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aComplement System Proteins
_xphysiology
650 0 4 _aCytotoxicity, Immunologic
650 0 4 _aFlow Cytometry
_xmethods
650 0 4 _aHumans
650 0 4 _aImmunoglobulin G
_xblood
650 0 4 _aLeukemia, Lymphocytic, Chronic, B-Cell
_ximmunology
650 0 4 _aMacrophage Activation
650 0 4 _aMacrophages
_ximmunology
650 0 4 _aReceptors, IgG
_xphysiology
650 0 4 _aRituximab
650 0 4 _aSerum
_xphysiology
700 1 _aKrause, Stefan W
700 1 _aSalcedo, Margarita
700 1 _aNardin, Alessandra
773 0 _tJournal of immunotherapy (Hagerstown, Md. : 1997)
_gvol. 29
_gno. 4
_gp. 388-97
856 4 0 _uhttps://doi.org/10.1097/01.cji.0000203081.43235.d7
_zAvailable from publisher's website
999 _c16392626
_d16392626